Pascal Biosciences Profit Margin

Pascal Biosciences (PSCBF) currently reports a profit margin of -21.03% as of May 2026. That compares with -13.12% in the prior-year period — down 60.2% year over year. That is below the sector sector average of 13.2%. Use the charts on this page to explore Pascal Biosciences's profit margin history and peer comparisons.

Pascal Biosciences's profit margin decreased from -13.12% to -21.03% — a 60.2% year-over-year decrease (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pascal Biosciences's profit margin of -21.03% is lower than the its sector sector average of 13.2%. That is roughly 259.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Pascal Biosciences's current -21.03% should be judged against industry norms (sector average: 13.2%) and against PSCBF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -21.03%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.2%. From there, open related valuation or income-statement pages for Pascal Biosciences, and consider following PSCBF for alerts when major investors trade the stock.